Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-08-03 21:21 |
Press Release: U.S. CDC Advisory Committee unanimously recommends routine use o…
|
English | PDF • 251.8 KB | ||
| 2023-07-28 21:35 |
6-K
|
English | ZIP • 348.5 KB | ||
| 2023-07-28 15:18 |
6-K
|
English | ZIP • 24.1 KB | ||
| 2023-07-28 13:22 |
Communiqué de presse : Mise en ligne du rapport financier semestriel 2023 de Sa…
|
French | PDF • 115.2 KB | ||
| 2023-07-28 13:22 |
Press release: Online availability of Sanofi’s half-year financial report for 2…
|
English | PDF • 107.8 KB | ||
| 2023-07-28 13:17 |
Sanofi : Rapport financier semestriel 2023
|
French | PDF • 577.1 KB | ||
| 2023-07-28 13:17 |
Sanofi : Rapport financier semestriel 2023
|
French | PDF • 15.2 MB | ||
| 2023-07-28 13:00 |
6-K
|
English | ZIP • 21.2 MB | ||
| 2023-07-28 07:32 |
Communiqué de presse : Sanofi va acquérir Qunol®, une marque américaine à crois…
|
French | PDF • 171.8 KB | ||
| 2023-07-28 07:32 |
Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healt…
|
English | PDF • 177.9 KB | ||
| 2023-07-28 07:30 |
Communiqué de presse : Solide performance au deuxième trimestre et forte progre…
|
French | PDF • 572.3 KB | ||
| 2023-07-28 07:30 |
Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 202…
|
English | PDF • 835.1 KB | ||
| 2023-07-24 18:43 |
6-K
|
English | ZIP • 31.7 KB | ||
| 2023-07-18 18:29 |
Sanofi: Informations relatives au nombre de droits de vote et d''actions - JUIN…
|
French | PDF • 118.9 KB | ||
| 2023-07-18 18:29 |
Sanofi: Information concerning the total number of voting rights and shares – J…
|
English | PDF • 142.4 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
